JPMorgan Chase & Co. Boosts Holdings in Ingevity Corporation $NGVT

JPMorgan Chase & Co. boosted its stake in Ingevity Corporation (NYSE:NGVTFree Report) by 66.8% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 126,080 shares of the company’s stock after acquiring an additional 50,498 shares during the period. JPMorgan Chase & Co.’s holdings in Ingevity were worth $6,958,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in NGVT. Oakworth Capital Inc. purchased a new stake in shares of Ingevity during the 3rd quarter worth approximately $28,000. Geneos Wealth Management Inc. grew its holdings in Ingevity by 85.8% during the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock valued at $36,000 after purchasing an additional 387 shares during the period. Headlands Technologies LLC bought a new position in Ingevity during the second quarter valued at $46,000. Elevation Point Wealth Partners LLC purchased a new stake in Ingevity in the second quarter worth $60,000. Finally, CIBC Private Wealth Group LLC bought a new stake in shares of Ingevity in the third quarter valued at $62,000. 91.59% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

NGVT has been the topic of a number of recent research reports. Wells Fargo & Company upped their price target on Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a research report on Friday, February 27th. Jefferies Financial Group restated a “buy” rating and issued a $82.00 price objective on shares of Ingevity in a research note on Thursday, February 26th. BMO Capital Markets reaffirmed an “outperform” rating and set a $83.00 price objective on shares of Ingevity in a report on Monday, March 2nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ingevity in a research report on Thursday, January 22nd. Finally, Wall Street Zen downgraded shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Monday, March 9th. Two investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Ingevity presently has a consensus rating of “Hold” and a consensus target price of $80.00.

View Our Latest Research Report on NGVT

Ingevity Trading Up 2.6%

Shares of NGVT opened at $71.35 on Wednesday. Ingevity Corporation has a twelve month low of $28.49 and a twelve month high of $77.46. The stock has a market cap of $2.52 billion, a PE ratio of -15.34 and a beta of 1.31. The company has a quick ratio of 0.79, a current ratio of 1.33 and a debt-to-equity ratio of 39.10. The business’s 50-day moving average price is $69.54 and its 200-day moving average price is $60.78.

Ingevity (NYSE:NGVTGet Free Report) last released its quarterly earnings data on Wednesday, February 25th. The company reported $0.58 EPS for the quarter, missing analysts’ consensus estimates of $0.74 by ($0.16). The firm had revenue of $255.10 million during the quarter, compared to the consensus estimate of $257.27 million. Ingevity had a negative net margin of 13.51% and a positive return on equity of 126.25%. Ingevity’s revenue was down 3.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.95 earnings per share. Ingevity has set its FY 2026 guidance at 4.800-5.20 EPS. On average, equities analysts forecast that Ingevity Corporation will post 4.45 EPS for the current fiscal year.

Ingevity Company Profile

(Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

Further Reading

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVTFree Report).

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.